Curtis Elizabeth M, Moon Rebecca J, D'Angelo Stefania, Raisi-Estabragh Zahra, Cooper Cyrus, Harvey Nicholas C
MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton General Hospital, Southampton United Kingdom.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital NHS Foundation Trust, Southampton, United Kingdom.
J Bone Miner Res. 2025 Jul 11. doi: 10.1093/jbmr/zjaf094.
We aimed to investigate associations between diabetes mellitus and incident fracture, stratified by diabetes type (1 or 2), disease duration and microvascular complications of diabetes. This prospective cohort analysis used data from the UK Biobank, a large population-based cohort of participants recruited 2006-2010 at age 40-69 yr. The exposure was type 1 or type 2 diabetes at baseline, with the outcome of first incident osteoporotic fracture. Poisson regression was used to calculate incidence rate ratios (IRRs) for osteoporotic fracture to investigate prospective relationships between diabetes type 1 or 2 and fracture risk independent of traditional clinical risk factors, estimated bone mineral density by heel ultrasound (eBMD), adiposity, and C-reactive protein. The role of diabetic microvascular complications and associations between diabetes duration and fracture risk were studied. There were 498 949 participants (271 882 women, mean age 56 yr; 227 067 men, 57 yr). In fully adjusted models, type 1 and 2 diabetes were associated with increased fracture risk [type 1; IRR: 2.93 (95%CI:2.37,3.62); type 2: 1.25 (1.14,1.38)], similar by sex. The magnitude of risk associated with type 2 diabetes increased with duration of disease. Increasing number of microvascular complications was associated with greater fracture risk [any vs no complications, IRR 2.03 (1.57,2.62)]. Diabetes is associated with increased risk of fracture (magnitude of effect greater in type 1 than type 2 diabetes). Associations were partly independent of traditional risk factors, adiposity, eBMD and CRP. Type 2 diabetes disease duration and the presence of microvascular complications in both types were dose-dependent risk factors for fracture.
我们旨在按糖尿病类型(1型或2型)、病程及糖尿病微血管并发症进行分层,研究糖尿病与新发骨折之间的关联。这项前瞻性队列分析使用了英国生物银行的数据,该数据库是一个基于人群的大型队列,研究对象为2006年至2010年招募的年龄在40至69岁的参与者。暴露因素为基线时的1型或2型糖尿病,结局为首次发生的骨质疏松性骨折。采用泊松回归计算骨质疏松性骨折的发病率比(IRR),以研究1型或2型糖尿病与骨折风险之间的前瞻性关系,该关系独立于传统临床风险因素、通过足跟超声估算的骨密度(eBMD)、肥胖及C反应蛋白。研究了糖尿病微血管并发症的作用以及糖尿病病程与骨折风险之间的关联。共有498949名参与者(271882名女性,平均年龄56岁;227067名男性,57岁)。在完全调整模型中,1型和2型糖尿病均与骨折风险增加相关[1型:IRR:2.93(95%CI:2.37,3.62);2型:1.25(1.14,1.38)],男女情况相似。与2型糖尿病相关的风险程度随病程延长而增加。微血管并发症数量增加与更高的骨折风险相关[有并发症与无并发症相比,IRR 2.03(1.57,2.62)]。糖尿病与骨折风险增加相关(1型糖尿病的效应幅度大于2型糖尿病)。这些关联部分独立于传统风险因素、肥胖、eBMD和CRP。2型糖尿病病程以及两种类型糖尿病中微血管并发症的存在都是骨折的剂量依赖性风险因素。